aTyr Pharma
Price & Volume
Stats
See more52W Range | $0.68-$7.29 |
Market Cap | $69.5M |
Shares Short | 33M |
Financials
See moreRevenue (12 Mos) | $0 |
Revenue Growth (YoY) | 0% |
Gross Profit (12 Mos) | -$54.2M |
Diluted EPS | -$0.79 |
News
See moreYahoo Finance • 22 hours ago
aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower – Hagens Berman
Yahoo Finance • 4 days ago
aTyr Pharma, Inc. (ATYR) Faces Investor Scrutiny After EFZO-FIT Study Failure Drives Shares 80% Lower -- Hagens Berman
Yahoo Finance • 4 days ago
aTyr Pharma Presents Additional Findings from Phase 3 EFZO-FIT™ Study in Late-Breaking Oral Abstract at the European Respiratory Society (ERS) Congress 2025
Yahoo Finance • 10 days ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of aTyr Pharma, Inc. - ATYR
About
CEO | Dr. Sanjay S. Shukla M.D., M.S. |
Address | 10240 Sorrento Valley Road, San Diego, CA, United States, 92121 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 56 |
